Clinical Study

The Positive Effects of One-Hour Intravenous Administration of Bortezomib on Peripheral Neuropathy in Multiple Myeloma Patients

Figure 1

Progression free survival (a) and overall survival (b).
237698.fig.001a
(a)
237698.fig.001b
(b)